BIT 7.50% 3.7¢ biotron limited

Approval of the drug wouldn't come before phase 2 human trials....

  1. 302 Posts.
    lightbulb Created with Sketch. 49
    Approval of the drug wouldn't come before phase 2 human trials. FDA has basically given them advice towards that approval, the message is we like what we see, let's see how human trials play out. The recommendation for a smaller phase 2 is important as it will cost less and we'll get the results quicker.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.003(7.50%)
Mkt cap ! $33.38M
Open High Low Value Volume
3.8¢ 4.0¢ 3.7¢ $13.74K 361.7K

Buyers (Bids)

No. Vol. Price($)
1 421052 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 19000 1
View Market Depth
Last trade - 15.39pm 05/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.